Global Amniotic Membrane Market Forecast 2022-2030

The global amniotic membrane market is predicted to record a CAGR of 7.03% during the forecast period, 2022-2030. The awareness programs for wound care treatment, the growing research on regenerative medicine and stem cell biology, and the increasing incidents of traumatic wounds and burn injuries propel market growth.

MARKET INSIGHTS

Amniotic membrane (AM) is a thin membrane that surrounds the embryo and has immunological, anti-viral, anti-bacterial, and anti-inflammatory properties. It is a non-tumorigenic tissue, promotes epithelialization, and finds applications in several surgical procedures.

Wound care treatment has been increasingly prioritized in recent years, with the growing traumatic wounds and burn injuries. As a result, doctors, researchers, and professionals are conducting awareness programs worldwide. For instance, the Wound Care Center at Carteret Health Care, the United States, helps raise awareness of chronic wounds. Also, several leading institutes are offering many programs for advanced wound care treatment using AM.

Besides, clinical treatments incorporate AM on a large scale to regenerate dead/damaged cells and heal wounds. Moreover, the process involves minimal costs, and therefore, such awareness programs are being focused upon by healthcare professionals. Such aspects of AM drive the global amniotic membrane market growth. However, the market growth is hampered by the limitations pertaining to amniotic membrane use.

REGIONAL INSIGHTS

The global amniotic membrane market growth assessment includes the geographical evaluation of North America, Europe, Asia-Pacific, and Rest of World. North America is set to be the largest revenue-generating region globally, with growing AM demands for swifter treatment of injuries.

COMPETITIVE INSIGHTS

The competitive rivalry is moderate. This is attributed to the new applications of AM in an emerging market with a large number of market players. Some of the eminent companies in the market are Bio-Tissue Inc, Amino X Medical Inc, SurgiLogix Llc, MiMedx, etc.

Our report offerings include:

Explore key findings of the overall market

Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

Market Segmentation cater to a thorough assessment of key segments with their market estimations

Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 43381

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. RISING INCIDENTS OF BURN INJURIES AND TRAUMATIC WOUNDS
- 3.1.2. INCREASING RESEARCH ON STEM CELL BIOLOGY AND REGENERATIVE MEDICINE
- 3.1.3. AWARENESS PROGRAMS FOR WOUND CARE TREATMENT
3.2. KEY RESTRAINTS
- 3.2.1. LIMITATIONS ASSOCIATED WITH USE OF AMNIOTIC MEMBRANE

4. KEY ANALYTICS

4.1. IMPACT OF COVID-19 ON AMNIOTIC MEMBRANE MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE

5. MARKET BY PRODUCT

5.1. CRYOPRESERVED AMNIOTIC MEMBRANE
5.2. LYOPHILIZATION AMNIOTIC MEMBRANE

6. MARKET BY APPLICATION

6.1. SURGICAL WOUNDS
6.2. OPHTHALMOLOGY
6.3. OTHER APPLICATIONS

7. MARKET BY END-USERS

7.1. HOSPITALS
7.2. AMBULATORY SURGICAL CENTERS
7.3. SPECIALIZED CLINICS
7.4. RESEARCH CENTERS & LABORATORIES

8. GEOGRAPHICAL ANALYSIS

8.1. NORTH AMERICA
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. KEY GROWTH ENABLERS
- 8.1.3. KEY CHALLENGES
- 8.1.4. KEY PLAYERS
- 8.1.5. COUNTRY ANALYSIS
  - 8.1.5.1. UNITED STATES
  - 8.1.5.2. CANADA
8.2. EUROPE
- 8.2.1. MARKET SIZE & ESTIMATES
- 8.2.2. KEY GROWTH ENABLERS
- 8.2.3. KEY CHALLENGES
- 8.2.4. KEY PLAYERS
- 8.2.5. COUNTRY ANALYSIS
  - 8.2.5.1. UNITED KINGDOM
  - 8.2.5.2. GERMANY
  - 8.2.5.3. FRANCE
  - 8.2.5.4. ITALY
  - 8.2.5.5. RUSSIA
  - 8.2.5.6. BELGIUM
  - 8.2.5.7. POLAND
  - 8.2.5.8. REST OF EUROPE
8.3. ASIA-PACIFIC
- 8.3.1. MARKET SIZE & ESTIMATES
- 8.3.2. KEY GROWTH ENABLERS
- 8.3.3. KEY CHALLENGES
- 8.3.4. KEY PLAYERS
- 8.3.5. COUNTRY ANALYSIS
  - 8.3.5.1. CHINA
  - 8.3.5.2. JAPAN
  - 8.3.5.3. INDIA
  - 8.3.5.4. SOUTH KOREA
  - 8.3.5.5. INDONESIA
  - 8.3.5.6. THAILAND
  - 8.3.5.7. VIETNAM
  - 8.3.5.8. AUSTRALIA & NEW ZEALAND
  - 8.3.5.9. REST OF ASIA-PACIFIC
8.4. REST OF WORLD
- 8.4.1. MARKET SIZE & ESTIMATES
- 8.4.2. KEY GROWTH ENABLERS
- 8.4.3. KEY CHALLENGES
- 8.4.4. KEY PLAYERS
- 8.4.5. REGIONAL ANALYSIS
  - 8.4.5.1. LATIN AMERICA
  - 8.4.5.2. MIDDLE EAST & AFRICA

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
9.2. COMPANY PROFILES
- 9.2.1. AMINO TECHNOLOGY LLC
- 9.2.2. AMINO X MEDICAL INC
- 9.2.3. BIO-TISSUE INC
- 9.2.4. CELULARITY INC
- 9.2.5. HUMAN REGENERATIVE TECHNOLOGIES
- 9.2.6. INTEGRA LIFESCIENCES CORP
- 9.2.7. KATENA PRODUCTS INC
- 9.2.8. LABTICIAN OPHTHALMICS INC
- 9.2.9. MIMEDX
- 9.2.10. ORGANOGENESIS INC
- 9.2.11. SKYE BIOLOGICS LLC
- 9.2.12. SMITH & NEPHEW PLC
- 9.2.13. STRYKER CORPORATION
- 9.2.14. SURGENEX LLC
- 9.2.15. SURGILOGIX LLC